Over at U.S. Politics Today, Joe Rothstein highlights the bogusness of the "public safety" argument against importing prescription drugs from Canada. But while Rothstein credits the Canadian government with protecting its citizens from the drug industry's "price gouging," David Henderson and Charley Hooper note in a recent Washington Times op-ed piece that the likely upshot of free trade in pharmaceuticals would be an end to Canadian price controls.
[Thanks to Mark Lambert for the Rothstein link.]
Start your day with Reason. Get a daily brief of the most important stories and trends every weekday morning when you subscribe to Reason Roundup.